HCA vs ENSG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 06, 2026

HCA

36.6
AI Score
VS
ENSG Wins

ENSG

39.1
AI Score

Investment Advisor Scores

HCA

37score
Recommendation
SELL

ENSG

39score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HCA ENSG Winner
Revenue 59.19B 4.31B HCA
Net Income 4.90B 303.67M HCA
Net Margin 8.3% 7.0% HCA
ROE -60.6% 11.9% ENSG
ROA 7.7% 5.1% HCA
Total Assets 63.45B 6.00B HCA
Cash 908.00M 337.59M HCA
Debt/Equity -5.54 0.08 HCA
Current Ratio 0.82 1.20 ENSG

Relative Price Performance (Last 90 Days)

HCA 1M: +9.8% · 3M: +22.9% ENSG 1M: +7.5% · 3M: +2.4%

Current Technical Phase

HCA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.8% over 20 days), RSI 65

RSI (14): 65.3 · Price: $506.04

ENSG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.2 · Price: $186.19

Fundamentals Snapshot

Metric HCA ENSG
Market Cap — —
Forward P/E 16.2 21.2
Trailing P/E 16.7 27.5
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.4% 0.2%
Operating Margin 0.1% 0.1%
EPS 30.12 6.72
Dividend Yield 0.01% 0.00%

Frequently Asked Questions

Based on our detailed analysis, ENSG is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.